Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Kawasaki Disease and Coronary Artery Involvement: A Narrative Review. | Cureus | 2022 | 36185934 | PubTator, text mining | PubMed |
| Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020. | Front Oncol | 2022 | 36185300 | PubTator, text mining | PubMed |
| Chaperonin containing TCP-1 (CCT/TRiC) is a novel therapeutic and diagnostic target for neuroblastoma. | Front Oncol | 2022 | 36185250 | PubTator, text mining | PubMed |
| AP2 Regulates Thickveins Trafficking to Attenuate NMJ Growth Signaling in Drosophila. | eNeuro | 2022 | 36180220 | PubTator, text mining | PubMed |
| Gender differences in genotypic distribution of endothelin-1 gene and endothelin receptor A gene in pulmonary hypertension associated with rheumatic mitral valve disease. | Indian Heart J | 2022 | 36179900 | PubTator, text mining | PubMed |
| A blood DNA methylation biomarker for predicting short-term risk of cardiovascular events. | Clin Epigenetics | 2022 | 36175966 | PubTator, text mining | PubMed |
| Atheroprone fluid shear stress-regulated ALK1-Endoglin-SMAD signaling originates from early endosomes. | BMC Biol | 2022 | 36171573 | PubTator, text mining | PubMed |
| Monoclonal anti-endoglin antibody TRC105 (carotuximab) prevents hypercholesterolemia and hyperglycemia-induced endothelial dysfunction in human aortic endothelial cells. | Front Med (Lausanne) | 2022 | 36160139 | PubTator, text mining | PubMed |
| Infant biliary cirrhosis secondary to a biliary inflammatory myofibroblastic tumor: A case report and review of literature. | World J Clin Cases | 2022 | 36159551 | PubTator, text mining | PubMed |
| Role of octreotide in small bowel bleeding. | World J Clin Cases | 2022 | 36159407 | PubTator, text mining | PubMed |
| Scleroderma-like Syndrome in the Setting of Pembrolizumab Therapy for Non-Small Cell Lung Cancer: Diagnosis and Dermatologic Management. | Case Rep Dermatol | 2022 | 36158854 | PubTator, text mining | PubMed |
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole-Exome Sequencing in a Patient with Delayed-Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1R206H -Specific Human Cellular and Zebrafish Models. | J Bone Miner Res | 2022 | 36153796 | PubTator, text mining | PubMed |
| FGF receptor inhibitor BGJ398 partially rescues osteoarthritis-like phenotype in older high molecular weight FGF2 transgenic mice via multiple mechanisms. | Sci Rep | 2022 | 36153352 | PubTator, text mining | PubMed |
| Hepatic factor may not originate from hepatocytes. | Front Cardiovasc Med | 2022 | 36148055 | PubTator, text mining | PubMed |
| Comprehensive analysis and validation of novel immune and vascular remodeling related genes signature associated with drug interactions in pulmonary arterial hypertension. | Front Genet | 2022 | 36147486 | PubTator, text mining | PubMed |
| FGFR-2 and Epithelial-Mesenchymal Transition in Endometrial Cancer. | J Clin Med | 2022 | 36143062 | PubTator, text mining | PubMed |
| Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study. | J Clin Med | 2022 | 36142926 | PubTator, text mining | PubMed |
| Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry. | Int J Mol Sci | 2022 | 36142358 | PubTator, text mining | PubMed |
| Could BMPs Therapy Be Improved if BMPs Were Used in Composition Acting during Bone Formation in Endochondral Ossification? | Int J Mol Sci | 2022 | 36142232 | PubTator, text mining | PubMed |
| The Gelatinase Inhibitor ACT-03 Reduces Gliosis in the Rapid Kindling Rat Model of Epilepsy, and Attenuates Inflammation and Loss of Barrier Integrity In Vitro. | Biomedicines | 2022 | 36140216 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=33